* Aspira Women's Health Inc AWH.OQ reported a quarterly
adjusted
loss of 39 cents per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -73 cents. The mean expectation of
four analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -37 cents
to -28 cents per share.
* Revenue fell 7% to $2.15 million from a year ago; analysts
expected $2.56 million.
* Aspira Women's Health Inc's reported EPS for the quarter
was a
loss of 39 cents.
* The company reported a quarterly loss of $4.63 million.
* Aspira Women's Health Inc shares had fallen by 6.5% this
quarter and lost 28.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 9% in
the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Aspira Women's
Health Inc is $5.25
This summary was machine generated from LSEG data May 15 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.33 -0.39 Missed
Dec. 31 2023 -0.45 -0.30 Beat
Sep. 30 2023 -0.51 -0.48 Beat
Jun. 30 2023 -0.55 -0.28 Beat